Spartan Peptides score history

Score over time

Every entry newest first

1. November 6, 2026Raised from3.32→to3.38(+0.06)

   Lab score recomputed under the published rule on 6 November 2026: lab 3.3 to 3.4.

2. November 2, 2026Lowered from3.43→to3.32(-0.11)

   Lab evidence re-checked on 2 November 2026. The TB-500 certificate's ID, read from its QR code, was confirmed at MZ Biolabs, so all six published certificates are now confirmed at the laboratory. Epithalon and NAD+, both sold on the site without a published certificate, were added to the products we list, so certificates cover 6 of 17 products and the third-party testing cap still applies. Lab 3.5 to 3.3.

3. October 24, 2026Raised from2.94→to3.43(+0.49)

   Two products added on 24 October 2026: MOTS-c and the CJC-1295 no DAC / ipamorelin blend, both sold on the vendor's site and covered by MZ Biolabs certificates (lot PEP-04-26) confirmed at the laboratory. Lab 2.6 to 3.5.

4. October 22, 2026Raised from2.66→to2.94(+0.28)

   Lab score recalculated on 22 October 2026 under the published core-product rule (A1b): a missing certificate on one of the 15 most widely carried products still counts fully, while on any other product it now counts at half weight, so a broad catalogue is not penalised as much for its breadth. Lab 2.1 to 2.6.

5. October 22, 2026Raised from2.55→to2.66(+0.11)

   Claim deductions re-checked on 22 October 2026 under the published rule that a claim deduction applies only where a site claim is contradicted by what its certificates show, never for products merely lacking a certificate. Lab 1.9 to 2.1.

6. October 22, 2026Lowered from2.58→to2.55(-0.03)

   Re-scored on 22 October 2026 under the published rulebook, which now gives one rule for each judgement call and applies it to every vendor: transparency 2.5 to 2.0.

7. October 22, 2026Raised from2.36→to2.58(+0.22)

   Re-scored on 22 October 2026 under version 2 of our published rules. The MZ Biolabs certificate IDs for BPC-157, GHK-Cu and Tesamorelin were confirmed at the laboratory, which raises those certificates. The testing gate is now computed from the certificates: 3 of 13 products have a certificate confirmed at a directory laboratory, fewer than the half required. Lab 1.5 to 1.9. Score 2.36 to 2.58.

8. October 22, 2026Lowered from3.34→to2.36(-0.98)

   Re-scored on 22 October 2026 under our published rubric for shipping, pricing, operating history and transparency, applied to every vendor the same day: prices re-read from the vendor's site and matched by milligrams per vial, operating history from the earliest dated evidence of the business, and policies scored item by item. shipping and refunds 6.5 to 5.5, pricing 3.3 to 1.0, operating history 9.0 to 3.1, transparency 5.3 to 2.5.

9. October 22, 2026Lowered from3.39→to3.34(-0.05)

   Lab score recalculated on 22 October 2026 under the uniform published rubric applied to every vendor: every listed product was rescored on the same fixed certificate points, with fixed deductions for one lot number printed on certificates for different compounds and site statements about testing that the certificates do not bear out. Lab 1.6 to 1.5.

10. October 20, 2026Lowered from5.26→to3.39(-1.87)

    Lab evidence re-checked on 20 October 2026 under our coverage rule, which counts a listed product with no published certificate as zero in the lab average. Certificates cover 4 of the 13 products we list that the vendor offers for sale. Lab 5.0 to 1.6.

11. July 23, 2026Raised from4.76→to5.26(+0.50)

    Re-audited from live COAs. Verified 6 MZ Biolabs reports (identity + purity, no sterility/heavy-metals); shipping was raised. COA coverage is still thin across the catalog, which caps the score.